Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Somatic Hypermutation of the YAP Oncogene in a Human Cutaneous Melanoma
Xiaomeng Zhang, Jian Tang, Ismael A. Vergara, et al.
Molecular Cancer Research (2019) Vol. 17, Iss. 7, pp. 1435-1449
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BioEssays (2020) Vol. 42, Iss. 5
Open Access | Times Cited: 215
Regulation of TEAD Transcription Factors in Cancer Biology
Hyunbin D. Huh, Dong Yeop Kim, Han-Sol Jeong, et al.
Cells (2019) Vol. 8, Iss. 6, pp. 600-600
Open Access | Times Cited: 214
YAP/TAZ as master regulators in cancer: modulation, function and therapeutic approaches
Stefano Piccolo, Tito Panciera, Paolo Contessotto, et al.
Nature Cancer (2022)
Open Access | Times Cited: 139
YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
Frank Szulzewsky, Eric C. Holland, Valeri Vasioukhin
Developmental Biology (2021) Vol. 475, pp. 205-221
Open Access | Times Cited: 111
Insights into recent findings and clinical application of YAP and TAZ in cancer
James Franklin, ZhengMing Wu, Kun‐Liang Guan
Nature reviews. Cancer (2023) Vol. 23, Iss. 8, pp. 512-525
Closed Access | Times Cited: 104
The Roles of YAP/TAZ and the Hippo Pathway in Healthy and Diseased Skin
Emanuel Rognoni, Gernot Walko
Cells (2019) Vol. 8, Iss. 5, pp. 411-411
Open Access | Times Cited: 81
The Hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis
Xiaomeng Zhang, Lie Yang, Pacman Szeto, et al.
Oncogene (2020) Vol. 39, Iss. 30, pp. 5267-5281
Open Access | Times Cited: 71
The Hippo Pathway as a Driver of Select Human Cancers
Aishwarya Kulkarni, Matthew T. Chang, Joseph H.A. Vissers, et al.
Trends in cancer (2020) Vol. 6, Iss. 9, pp. 781-796
Closed Access | Times Cited: 65
The role of yes activated protein (YAP) in melanoma metastasis
Andrew Leask, John Nguyen, Angha Naik, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109864-109864
Open Access | Times Cited: 7
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni, Enrica T. Tanda, Bruna Dalmasso, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 32
Nuclear Import and Export of YAP and TAZ
Michael Kofler, András Kapùs
Cancers (2023) Vol. 15, Iss. 20, pp. 4956-4956
Open Access | Times Cited: 11
Bcl-2 dependent modulation of Hippo pathway in cancer cells
Simona D’Aguanno, Matteo Brignone, Stefano Scalera, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors
Bodo C. Melnik, Swen Malte John, Pedro Carrera‐Bastos, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2111-2111
Open Access | Times Cited: 28
Inactivation of the Hippo tumor suppressor pathway promotes melanoma
Marc A. Vittoria, Nathan Kingston, Kristýna Kotýnková, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside
Xiaoli Liu, Yifei Wang, Bonan Chen, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2512-2512
Open Access | Times Cited: 17
Identification of a Gene Signature That Predicts Dependence upon YAP/TAZ-TEAD
Ryan Kanai, Emily Norton, Patrick Stern, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 852-852
Open Access | Times Cited: 3
Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence
Viola Kluge, Melanie Kappelmann‐Fenzl, Stefan Fischer, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 3
An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
Giampaolo Morciano, Bianca Vezzani, Sonia Missiroli, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 3100-3100
Open Access | Times Cited: 21
MOB3A Bypasses BRAF and RAS Oncogene-Induced Senescence by Engaging the Hippo Pathway
Kendall Dutchak, Sam Garnett, Mary Nicoll, et al.
Molecular Cancer Research (2022) Vol. 20, Iss. 5, pp. 770-781
Open Access | Times Cited: 14
YAP facilitates melanoma migration through regulation of actin‐related protein 2/3 complex subunit 5 (ARPC5)
Jason W. Lui, Stephen P.G. Moore, Lee Huang, et al.
Pigment Cell & Melanoma Research (2021) Vol. 35, Iss. 1, pp. 52-65
Open Access | Times Cited: 18
Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
Alexander Howard, Jodie Bojko, Benjamin P. Flynn, et al.
Experimental Dermatology (2022) Vol. 31, Iss. 10, pp. 1477-1499
Open Access | Times Cited: 13
Role of hippo pathway and cuproptosis-related genes in immune infiltration and prognosis of skin cutaneous melanoma
Haozhen Lv, Lin Liu, Yuexi He, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
A Framework of Major Tumor-Promoting Signal Transduction Pathways Implicated in Melanoma-Fibroblast Dialogue
Barbara Bellei, Emilia Migliano, Mauro Picardo
Cancers (2020) Vol. 12, Iss. 11, pp. 3400-3400
Open Access | Times Cited: 20
Disruption of LTBP4 Inhibition-Induced TGFβ1 Activation Promoted Cell Proliferation and Metastasis in Skin Melanoma by Inhibiting the Activation of the Hippo-YAP1 Signaling Pathway
Lina Wang, Dong-run Tang, Tong Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 12
USP22 promotes melanoma and BRAF inhibitor resistance via YAP stabilization
Ying Wei, Ziyun Jiang, Jianfeng Lü
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top